Managing asthma in adults

American Journal of Managed Care

Volumn 6, Issue 17 SUPPL., 2000, Pages

  Creticos, Peter S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLOVENT DISKUS; FLUTICASONE; FLUTICASONE PLUS SALMETEROL; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLXANTHINE; MOMETASONE FUROATE; MONTELUKAST; NEDOCROMIL; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDOLEUKOTRIENE; PREDNISONE; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE; TERBUTALINE; THEOPHYLLINE; TRIAMCINOLONE; UNCLASSIFIED DRUG; ZAFIRLUKAST; ZILEUTON;

ADJUVANT THERAPY; ADRENAL SUPPRESSION; ASTHMA; BONE DEMINERALIZATION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG FORMULATION; DRUG POTENTIATION; ENVIRONMENTAL FACTOR; GASTROESOPHAGEAL REFLUX; HEALTH CARE MANAGEMENT; HUMAN; IMMUNOTHERAPY; MANAGED CARE; NONHUMAN; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; SIDE EFFECT;

ADULT; AIR POLLUTION, INDOOR; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; HUMANS; PATIENT EDUCATION; PRACTICE GUIDELINES; UNITED STATES;

EID: 0033794505     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (77)

1. Immunologic changes associated with immunotherapy: Immunotherapy of IgE-mediated disorders
2. Regulation of IL-4, IL-5 and GM-CSF in T lymphocytes
3. T lymphocytes in chronic asthma
4. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses
5. Mediator release after nasal challenge with allergen
6. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed
7. Inflammatory mediators in late antigen-induced rhinitis
8. Direct evidence of a role for mast cells in the pathogenesis of antigen-induced bronchoconstriction
9. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics
10. Patient education in the United States
11. Immunochemical quantitation of airborn short ragweed, Alternaria, antigen E, and Alt-1 allergens: A two-year prospective study
12. Inhaled glucocorticoids for asthma
13. Antiinflammatory actions of glucocorticoids: Molecular mechanisms
14. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial
15. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma
16. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
17. Effect of early vs late intervention with inhaled corticosteroids in asthma
18. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic applications in asthma
19. Anti-inflammatory actions of steroids: Molecular mechanisms
20. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 cx, 17 cx acetal-substituted glucocorticoids
21. Pharmacodynamics and pharmacokinetics of inhaled gluco-corticoids
22. Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids
23. Establishing a therapeutic index for the inhaled corticosteroids: Part II
24. Side effects of inhaled corticosteroids
25. Issues in the use of inhaled glucocorticoids
26. Growth in asthmatic children treated with fluticasone propionate
27. Cromolyn sodium: A review
28. A multicenter evaluation of the clinical benefits of cromolyn sodium aerosol by metered-dose inhaler in the treatment of asthma
29. Cromolyn sodium is effective in adult chronic asthmatics
30. Effects of nedocromil sodium on inflammation and symptoms in therapeutic studies
31. The long-term effects of nedocromil sodium and beclomethasone depropionate on bronchial responsiveness to methacholine in nonatopic asthma subjects
32. A 3-month evaluation of the efficacy of nedocromil sodium in asthma: A randomized, double-blind, placebo-controlled trial of nedocromil sodium conducted by a Canadian multicenter study group
33. A double-blind multicenter group comparative study of the efficacy and safety of nedocromil sodium in the management of asthma
34. The use of twice daily nedocromil sodium in the treatment of asthma
35. Alternative agents for anti-inflammatory treatment of asthma
36. Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airway disease
37. The effect of salmeterol on nocturnal symptoms, airway function and inflammation in asthma
38. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma
39. Asthma in adults
40. The role of leukotrienes in inflammation
41. Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapy. Review
42. The Zileuton study group. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial
43. Zafirlukast for symptomatic mild-to-moderate asthma: A 13-week multicenter study
44. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma
45. Montelukast added to inhaled beclomethasone in treatment of asthma
46. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma
47. Salmeterol added to inhaled corticosteroids provides greater asthma control compared to monelukast
48. Asthma
49. Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1 fl and TNFa: Effects of IL-10 and corticosteroids
50. Cytokine- and virus- stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines
51. Drug therapy of asthma
52. Effect of fluticasone propionate and salmeterol on Pseudomonas aeruginosa infection of respiratory mucosa in vitro
53. The effect of salmeterol xinafoate on lung mucociliary clearance in patients with stable asthma
54. The effects of salmeterol and salbutamol on ciliary beat frequency of cultured human bronchial epithelial cells, in vitro
55. 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells
56. Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation
57. Salmeterol facilitation of fluticasone-induced apoptosis in eosinophils of asthmatics pre- and post-antigen challenge
58. 2-adrenergic receptor function in human nasal mucosa
59. Bronchial biopsy study in asthmatics treated with low-and high-dose fluticasone propionate (FP) compared to low-dose FP combined with salmeterol
60. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
61. Salmeterol added to inhaled corticosteroid therapy is superior therapy is superior to doubling the dose of inhaled corticosteroids: A randomized clinical trial
62. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases
63. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma
64. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma
65. Inhaled salmeterol and fluticasone propionate: A study comparing monotherapy and combination therapy in asthma
66. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma
67. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized double-blind, placebo controlled trial
68. Combined salmeterol 50 mcg and fluticasone propionate 250 mcg in the DISKUS device for the treatment of asthma
69. Salmeterol/fluticasone propionate (50/500 mcg in combination in a DISKUS inhaler (Seretide) is effective and safe in the treatment of steroid dependent asthma
70. Exacerbations of asthma
71. The combination of salmeterol and low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations
72. The consideration of immunotherapy in the treatment of allergic asthma
73. Ragweed immunotherapy in adult asthma